Exact Sciences, Gastro Health & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

Advertisement

Motus GI named Jeff Hutchison vice president of U.S. sales and commercial operations.

Motus GI released its second quarter 2018 financial results, posting a $4.2 million net loss, or $0.27 per diluted share.

Exact Sciences, the manufacturer of Cologuard, and the Green Bay Packers launched “Crossing the 50,” a new campaign to raise money for the Vince Lombardi Cancer Foundation.

Miami-based Gastro Health made a series of leadership appointments as the practice continues to expand.

The FDA awarded Array Biopharma’s mutant metastatic colorectal cancer treatment the breakthrough therapy designation.

More articles on gastroenterology:
‘U.S. News and World Report’ names the top 10 hospitals for GI
Motion filed to limit media contact for gastroenterologist accused of sexual misconduct
ASGE recognizes Chicago gastroenterologist for quality: 4 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.